The risk of stomach cancer in patients with gastric or duodenal ulcer disease

New England Journal of Medicine

Volumn 335, Issue 4, 1996, Pages 242-249

  Hansson, Lars Erik ^a,c   Nyrén, Olof ^a   Hsing, Ann W ^d   Bergström, Reinhold ^a,b   Josefsson, Staffan ^a   Chow, Wong Ho ^e   Fraumeni Jr , Joseph F ^d   Adami, Hans Olov ^a,f  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c MORA HOSPITAL   (Sweden)

^d NATIONAL CANCER INSTITUTE   (United States)

^e INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHRONIC GASTRITIS; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH ULCER; SWEDEN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; SEX FACTORS; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 0030005551     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199607253350404     Document Type: Article

References (53)

1. Cruveilhier J. Anatomic pathologique du corps humain. Paris: Chez J.B. Baillière, 1835-1842.
2. Yamagata S, Hisamichi S. Prccancerous lesions of the stomach. World J Surg 1979;3:671-3.
3. Krause U. Long term results of medical and surgical treatment of peptic ulcer: a follow-up investigation of patients initially treated conservatively between 1925-34. Acta Chir Scand Suppl 1963;310:1-111.
4. Ihre BJE, Barr H, Havermark G. Ulcer-cancer of the stomach: a follow-up study of 473 cases of gastric ulcer. Gastroenterologia 1964;102: 78-91.
5. Westlund K. Mortality of peptic ulcer patients. Oslo, Norway: Universitetsforlaget, 1963.
6. Hirohata T. Mortality from gastric cancer and other causes after medical or surgical treatment for gastric ulcer. J Natl Cancer Inst 1968;41:895-908.
7. Hole DJ, Quigley EMM, Gillis CR, Watkinson G. Peptic ulcer and cancer: an examination of the relationship between chronic peptic ulcer and gastric carcinoma. Scand J Gastroenterol 1987;22:17-23.
8. Lee S, Iida M, Yao T, et al. Risk of gastric cancer in patients with non-surgically treated peptic ulcer. Scand J Gastroenterol 1990;25: 1223-6.
9. Lewis JH, Woods M III. Gastric carcinoma in patients with unoperated duodenal ulcer disease. Am J Gastroenterol 1982;77:368-73.
10. Norfleet RG, Johnson SE. Strange bedfellows: duodenal ulcer and cancer of the stomach. J Clin Gastroenterol 1989;11:382-5.
11. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991;13:42-59.
12. Muñoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev 1994;3:445-51.
13. Nyrén O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1995;87:28-33.
14. International statistical classification of diseases, injuries, and causes of death. 1955 rev. Stockholm, Sweden: Kungl. Medicinalstyrelsen, 1965.
15. International statistical classification of diseases, injuries, and causes of death. 1968 rev. Stockholm, Sweden: National Board of Health and Welfare, 1973.
16. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
17. Bailar JC III, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964;20:639-43.
18. Spiro HM. Clinical gastroenterology, 4th ed. New York: McGraw-Hill, 1993.
19. Kawashima T. Epidemiological study on the risk of gastric cancer in patients with duodenal ulcer. Nippon Shokakibyo Gakkai Zasshi 1991;88: 1161-7. (In Japanese.)
20. Dooley CP, Larson AW, Stace NH, et al. Double-contrast barium meal and upper gastrointestinal endoscopy: a comparative study. Ann Intern Med 1984;101:538-45.
21. Dekker W, Tytgat GN. Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy: a follow-up analysis. Gastroenterology 1977;73:710-4.
22. Lundegårdh G, Ekbom A, McLaughlin JK, Nyrén O. Gastric cancer risk after vagotomy. Gut 1994;35:946-9.
23. Lundegårdh G, Adami H-O, Helmick C, Zack M, Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 1988;319:195-200.
24. Somerville KW, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;1:462-4.
25. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992;103:862-9.
26. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
27. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-7.
28. Adami H-O, Bergström R, Nyrén O, et al. Is duodenal ulcer really a psychosomatic disease? A population-based case-control study. Scand J Gastroenterol 1987;22:889-96.
29. Kato I, Nomura AMY, Stemmermann GN, Chyou P-H. A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol, and diet. Am J Epidemiol 1992;135:521-30.
30. Hansson L-E, Baron J, Nyrén O, Bergström R, Wolk A, Adami H-O. Tobacco, alcohol and the risk of gastric cancer: a population-based casecontrol study in Sweden. Int J Cancer 1994;57:26-31.
31. Ellis DJ, Kingston RD, Brookes VS, Waterhouse JAH. Gastric carcinoma and previous peptic ulceration. Br J Surg 1979;66:117-9.
32. Nagayo T. Histogenesis and precursors of human gastric cancer. Berlin, Germany: Springer-Verlag, 1986:115.
33. Wong J, Ong GB. Gastric carcinoma developing in chronic gastric ulcer in the rat treated with N-methyl-N1-nitro-N-nitrosoguanidine. J Surg Res 1980;29:446-50.
34. Agréus L, Engstrand L, Svärdsudd K, Nyrén O, Tibblin G. Helicobacter pylori scropositivity among Swedish adults with and without abdominal symptoms: a population-based epidemiologic study. Scand J Gastroenterol 1995;30:752-7.
35. Infection with Helicobacter pylori. In: World Health Organization. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer, 1994:177-240.
36. Jackson JH, Gajewski E, Schraufstatter IU, et al. Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest 1989;84: 1644-9.
37. Iyengar R, Stuehr DJ, Marletta MA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci U S A 1987;84:6369-73.
38. Dutertre Y, Haglund O, Bioteau O, Engstrand L. Helicobacter pylori induced nitric oxide production in murine macrophages. Acta Gastroenterol Belg 1993;56:Suppl:61. abstract.
39. Cahill RJ, Beattie S, Hamilton H, Morain CO. Cell proliferation in the progression from normal mucosa to gastric carcinoma. Acta Gastroenterol Belg 1993;56:Suppl:61. abstract.
40. Lechago J, Correa P. Prolonged achlorhydria and gastric neoplasia: is there a causal relationship? Gastroenterology 1993;104:1554-7
41. Kekki M, Sipponen P, Siurala M, Laszewicz W. Peptic ulcer and chronic gastritis: their relation to age and sex, and to location of ulcer and gastritis. Gastroenterol Clin Biol 1990;14:217-23.
42. Schrager J, Spink R, Mitra S. The antrum in patients with duodenal and gastric ulcers. Gut 1967;8:497-508.
43. Sipponen P. Long-term consequences of gastroduodenal inflammation. Eur J Gastroenterol Hepatol 1992;4:Suppl 2:S25-S29.
44. Kuipers EJ, Uyterlinde AM, Peña AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-8.
45. Tsugane S, Kabuto M, Imai H, et al. Helioubacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993;4:297-305.
46. Eidt S, Stolte M. Antral intestinal metaplasia in Helicobacter pylori gastritis. Digestion 1994;55:13-8.
47. Camels S, Bereziat JC, Oshima H, Bartsch H. Bacterial formation of N-nitroso compounds in rats after omeprazole-induced achlorhydria. In: O'Neill IK, Chen J, Bartsch H, eds. Relevance to human cancer of N-nitroso compounds, tobacco smoke and mycotoxins. Lyon, France: International Agency for Research on Cancer, 1991:187-91. (IARC scientific publications no. 105.)
48. Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989;97:357-63.
49. Bartsch H, Ohshima H, Pignatelli B. Inhibitors of endogenous nitrosation: mechanisms and implications in human cancer prevention. Mutat Res 1988;202:307-24.
50. Rood JC, Ruiz B, Fontham ETH, et al. Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer 1994;22:65-72.
51. Simpson EH. The interpretation of interaction in contingency tables. J R Stat Soc [B] 1951;13:238-41.
52. Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer a population-based cohort study. Cancer 1993;71:745-50.
53. Møller H, Nissen A, Mosbech J. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users. Gut 1992;33:1166-9.